Atle - Active management

Latest news from us

Atle

Portfolio

Contact

About

News

Team

HealthInvest profiles seven female leaders reshaping global healthcare — from the Head of Oncology Research at AstraZeneca to the Chair of the Board at Abivax. Meet the women behind tomorrow's medical breakthroughs.

From AstraZeneca to Abivax – Seven Female Leaders Reshaping Medical Innovation | HealthInvest – Atle

From AstraZeneca to Abivax – Seven Female Leaders Reshaping Medical Innovation

Jane Austen's novels are a window into early capital markets and the overlooked role of female investors. Humle Fonder explain what Mr Darcy's income can tell us about financial history.

What Jane Austen Can Teach Us About Capital Markets | Atle

What Jane Austen Can Teach Us About Capital Markets

Humle Fonder, part of Atle, challenges industry norms with a savings calculator that shows realistic outcomes — not just best-case scenarios. The tool simulates hundreds of market paths and accounts for fees and taxes.

Can You Trust Your Savings Calculator? Humle Fonder Thinks Not | Atle

Can You Trust Your Savings Calculator? Humle Fonder Thinks Not

Per Svenningsson, one of the experts on HealthInvest’s Medical Council, has been appointed chair of the Nobel Committee for the Nobel Prize in Physiology or Medicine.

HealthInvest advisor appointed chair of Nobel Committee

Anders Byström is joining Atle’s Investor Relations team, where he will work with several of the group’s brands. Together with the rest of the IR team, he will play a central role in the dialogue with distributors, advisers and investors around Atle’s specialized fund companies.

New hire joins Atle’s Investor Relations team

See some of our 2025 highlights – the people behind the numbers, sector rotations, new funds, new colleagues and, of course, plenty of lessons learned along the way.